[go: up one dir, main page]

AU2001255375A1 - Compositions comprising a methylnogarol in combination with an antiproliferative agent - Google Patents

Compositions comprising a methylnogarol in combination with an antiproliferative agent

Info

Publication number
AU2001255375A1
AU2001255375A1 AU2001255375A AU5537501A AU2001255375A1 AU 2001255375 A1 AU2001255375 A1 AU 2001255375A1 AU 2001255375 A AU2001255375 A AU 2001255375A AU 5537501 A AU5537501 A AU 5537501A AU 2001255375 A1 AU2001255375 A1 AU 2001255375A1
Authority
AU
Australia
Prior art keywords
methylnogarol
compositions
combination
antiproliferative agent
antiproliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255375A
Inventor
Dennis M. Brown
Shawnya J. Michaels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ChemGenex Pharmaceuticals Inc
Original Assignee
ChemGenex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ChemGenex Therapeutics Inc filed Critical ChemGenex Therapeutics Inc
Publication of AU2001255375A1 publication Critical patent/AU2001255375A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001255375A 2000-04-12 2001-04-12 Compositions comprising a methylnogarol in combination with an antiproliferative agent Abandoned AU2001255375A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19710600P 2000-04-12 2000-04-12
US60/197,106 2000-04-12
PCT/US2001/012174 WO2001080842A2 (en) 2000-04-12 2001-04-12 Compositions comprising a methylnogarol in combination with an antiproliferative agent

Publications (1)

Publication Number Publication Date
AU2001255375A1 true AU2001255375A1 (en) 2001-11-07

Family

ID=22728074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255375A Abandoned AU2001255375A1 (en) 2000-04-12 2001-04-12 Compositions comprising a methylnogarol in combination with an antiproliferative agent

Country Status (3)

Country Link
US (1) US20020022652A1 (en)
AU (1) AU2001255375A1 (en)
WO (1) WO2001080842A2 (en)

Also Published As

Publication number Publication date
WO2001080842A2 (en) 2001-11-01
WO2001080842A3 (en) 2002-08-22
US20020022652A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
SG94799A1 (en) Chemically amplified positive resist composition
AU2001296443A1 (en) Compositions comprising arabinogalactan and a defined protein component
AU2001271397A1 (en) Component models
SG99336A1 (en) Chemically amplified positive resist composition
SG94738A1 (en) Chemically amplified positive resist composition
SG87205A1 (en) Chemically amplified positive resist composition
EP1151667A3 (en) Plant-activating agent
AU2888602A (en) Interferons, uses and compositions related thereto
AUPR105300A0 (en) Electronic international trading
AU2002234081A1 (en) Rapid development in a distributed application environment
AU2001265305A1 (en) Compositions containing hexitol and an antiproliferative agent
AU2002301354A1 (en) Improvements in Transmissometers
AU2002301358A1 (en) Improvements in Transmissometers
AU6979701A (en) Compositions with low irritancy
AU2002246542A1 (en) Antiproliferative colchicine compositions and uses thereof
AU2001280276A1 (en) Arrangement in a chair
AU2001255375A1 (en) Compositions comprising a methylnogarol in combination with an antiproliferative agent
AU2001287962A1 (en) A ball
AU2000251520A1 (en) Antiviral methods and compositions
AUPQ852400A0 (en) Pallet
GB0008274D0 (en) Improvements in ladders
AU2001252710A1 (en) Chemically amplified resist and a resist composition
AU2001284465A1 (en) Tetraphenylporphyrin derivatives and compositions comprising the same
GB0013400D0 (en) A formulation